Mechanisms of drug-induced immunologically mediated cytopenias.
Shulman
N R
NR
Clinical Hematology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892.
Reid
D M
DM
D001327:Autoimmune Diseases / Q000276:immunology*; D001773:Blood Cells / Q000276:immunology*; D006046:Gold / Q000009:adverse effects; D006241:Haptens; D006402:Hematologic Diseases / Q000139:chemically induced* / Q000276:immunology*; D006801:Humans; D008750:Methyldopa / Q000009:adverse effects
D006241:Haptens; D008750:Methyldopa; D006046:Gold